Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 851841, 7 pages
http://dx.doi.org/10.1155/2015/851841
Review Article

Regulation of miRNAs Affects Radiobiological Response of Lung Cancer Stem Cells

1Cancer Institute of PLA, Xinqiao Hospital, Third Military Medical University, Shapingba District, Chongqing 400037, China
2Medical English Department, College of Basic Medicine, Third Military Medical University, Shapingba District, Chongqing 400038, China

Received 17 December 2014; Accepted 14 February 2015

Academic Editor: Sherven Sharma

Copyright © 2015 Yan-mei Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. D. S. Ettinger, W. Akerley, H. Borghaei et al., “Non-small cell lung cancer: clinical practice guidelines in oncology,” Journal of the National Comprehensive Cancer Network, vol. 10, no. 10, pp. 1236–1271, 2012. View at Google Scholar · View at Scopus
  3. A.-R. Jazieh, H. Bamefleh, A. Demirkazik et al., “Modification and implementation of NCCN guidelines on non-small cell lung cancer in the Middle East and North Africa region,” Journal of the National Comprehensive Cancer Network, vol. 8, supplement 3, pp. S16–S21, 2010. View at Google Scholar · View at Scopus
  4. A. van Baardwijk, W. A. Tomé, W. van Elmpt et al., “Is high-dose stereotactic body radiotherapy (SBRT) for stage i non-small cell lung cancer (NSCLC) overkill? A systematic review,” Radiotherapy and Oncology, vol. 105, no. 2, pp. 145–149, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Senthi, C. J. A. Haasbeek, B. J. Slotman, and S. Senan, “Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review,” Radiotherapy and Oncology, vol. 106, no. 3, pp. 276–282, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Tyldesley, C. Boyd, K. Schulze, H. Walker, and W. J. Mackillop, “Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach,” International Journal of Radiation Oncology Biology Physics, vol. 49, no. 4, pp. 973–985, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Dessard-Diana, D. Manoux, C. Diana, M. Housset, and F. Baillet, “Discussion on the role of radiotherapy in non-small cell lung cancer apropos of 137 non-metastatic cases,” Cancer Radiothérapie, vol. 1, no. 2, pp. 154–158, 1997. View at Google Scholar
  8. S.-H. Chiou, C.-L. Kao, Y.-W. Chen et al., “Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor,” PLoS ONE, vol. 3, no. 5, Article ID e2090, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Bao, Q. Wu, R. E. McLendon et al., “Glioma stem cells promote radioresistance by preferential activation of the DNA damage response,” Nature, vol. 444, no. 7120, pp. 756–760, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Pajonk, E. Vlashi, and W. H. McBride, “Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited,” Stem Cells, vol. 28, no. 4, pp. 639–648, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Lapidot, C. Sirard, J. Vormoor et al., “A cell initiating human acute myeloid leukaemia after transplantation into SCID mice,” Nature, vol. 367, no. 6464, pp. 645–648, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. Á. Fábián, G. Vereb, and J. Szöllősi, “The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy,” Cytometry Part A, vol. 83, no. 1, pp. 62–71, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Shi, X. Fu, Y. Hua, Y. Han, Y. Lu, and J. Wang, “The side population in human lung cancer cell line NCI-H460 is enriched in stem-like cancer cells,” PLoS ONE, vol. 7, no. 3, Article ID e33358, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. M. M. Ho, A. V. Ng, S. Lam, and J. Y. Hung, “Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells,” Cancer Research, vol. 67, no. 10, pp. 4827–4833, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Singh, N. Bora-Singhal, J. Kroeger, H. Laklai, and S. P. Chellappan, “βarrestin-1 and Mcl-1 modulate self-renewal growth of cancer stem-like side-population cells in non-small cell lung cancer,” PLoS ONE, vol. 8, no. 2, Article ID e55982, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Cao, J. Jia, L. Ma et al., “Recombinant human endostatin could eliminate the pro-angiogenesis priority of SP cells sorted from non-small cell lung cancer cells,” Clinical and Translational Oncology, vol. 14, no. 8, pp. 575–585, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. C. F. Bender Kim, E. L. Jackson, A. E. Woolfenden et al., “Identification of bronchioalveolar stem cells in normal lung and lung cancer,” Cell, vol. 121, no. 6, pp. 823–835, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Eramo, F. Lotti, G. Sette et al., “Identification and expansion of the tumorigenic lung cancer stem cell population,” Cell Death and Differentiation, vol. 15, no. 3, pp. 504–514, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Wang, Z. Suo, M. Wang et al., “In vitro and in vivo properties of CD133 expressing cells from human lung cancer cell lines,” Experimental Hematology & Oncology, vol. 2, no. 1, article 16, 2013. View at Publisher · View at Google Scholar
  20. X. Meng, M. Li, X. Wang, Y. Wang, and D. Ma, “Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells,” Cancer Science, vol. 100, no. 6, pp. 1040–1046, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Lin, J.-G. Sun, J.-B. Wu et al., “Aberrant microRNAs expression in CD133+/CD326+ human lung adenocarcinoma initiating cells from A549,” Molecules and Cells, vol. 33, no. 3, pp. 277–283, 2012. View at Publisher · View at Google Scholar
  22. E. L.-H. Leung, R. R. Fiscus, J. W. Tung et al., “Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties,” PLoS ONE, vol. 5, no. 11, Article ID e14062, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Okudela, T. Woo, H. Mitsui, M. Tajiri, M. Masuda, and K. Ohashi, “Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma-their prognostic significance,” Pathology International, vol. 62, no. 12, pp. 792–801, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Li, L. Wan, J. Geng, C.-L. Wu, and X. Bai, “Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome,” Journal of Thoracic Oncology, vol. 7, no. 8, pp. 1235–1245, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. W. C. Zhang, N. Shyh-Chang, H. Yang et al., “Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis,” Cell, vol. 148, no. 1-2, pp. 259–272, 2012. View at Google Scholar
  26. F. Karimi-Busheri, V. Zadorozhny, T. Li, H. Lin, D. L. Shawler, and H. Fakhrai, “Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells,” Journal of Stem Cells, vol. 6, no. 1, pp. 9–20, 2011. View at Google Scholar · View at Scopus
  27. Y. Zheng, C. C. de la Cruz, L. C. Sayles et al., “A rare population of CD24+ITGB4+Notchhi cells drives tumor propagation in NSCLC and requires Notch3 for self-renewal,” Cancer Cell, vol. 24, no. 1, pp. 59–74, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. Z. Xiao, Q. Jiang, J. Willette-Brown et al., “The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas,” Cancer Cell, vol. 23, no. 4, pp. 527–540, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. G.-Y. Chiou, J.-Y. Cherng, H.-S. Hsu et al., “Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma,” Journal of Controlled Release, vol. 159, no. 2, pp. 240–250, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Zhang, Y. Wu, D. Feng et al., “miR-145 inhibits lung adenocarcinoma stem cells proliferation by targeting OCT4 gene,” Chinese Journal of Lung Cancer, vol. 14, no. 4, pp. 317–322, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Song, C. Lin, Z. Wu et al., “MiR-18a impairs DNA damage response through downregulation of Ataxia telangiectasia mutated (ATM) kinase,” PLoS ONE, vol. 6, no. 9, Article ID e25454, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. K. M. Lee, E. J. Choi, and I. A. Kim, “MicroRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling,” Radiotherapy and Oncology, vol. 101, no. 1, pp. 171–176, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Chen, H. Wang, W. L. Ng, W. J. Curran, and Y. Wang, “Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level,” International Journal of Radiation Oncology Biology Physics, vol. 81, no. 5, pp. 1524–1529, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Yan, W. L. Ng, X. Zhang et al., “Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation,” PLoS ONE, vol. 5, no. 7, Article ID e11397, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Grosso, J. Doyen, S. K. Parks et al., “MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines,” Cell Death and Disease, vol. 4, no. 3, article e544, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. Q. Li, X. Li, Z. Guo et al., “MicroRNA-574-5p was pivotal for TLR9 signaling enhanced tumor progression via down-regulating checkpoint suppressor 1 in human lung cancer,” PLoS ONE, vol. 7, no. 11, Article ID e48278, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Hu, S. Li, J. Liu, and B. Ni, “MicroRNA-193b modulates proliferation, migration, and invasion of non-small cell lung cancer cells,” Acta Biochimica et Biophysica Sinica, vol. 44, no. 5, pp. 424–430, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. X. Dang, A. Ma, L. Yang et al., “MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells,” Cancer Genetics, vol. 205, no. 3, pp. 113–123, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Saito, H. I. Suzuki, M. Horie et al., “An integrated expression profiling reveals target genes of TGF-beta and TNF-alpha possibly mediated by microRNAs in lung cancer cells,” PLoS ONE, vol. 8, no. 2, Article ID e56587, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Cao, M. Seike, C. Soeno et al., “MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells,” International Journal of Oncology, vol. 41, no. 3, pp. 869–875, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Zhi-Yong, Z. Guang-Ling, W. Mei-Mei, X. Ya-Nan, and C. He-Qin, “MicroRNA-663 targets TGFB1 and regulates lung cancer proliferation,” Asian Pacific Journal of Cancer Prevention, vol. 12, no. 11, pp. 2819–2823, 2011. View at Google Scholar · View at Scopus
  42. I. A. Babar, J. Czochor, A. Steinmetz, J. B. Weidhaas, P. M. Glazer, and F. J. Slack, “Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells,” Cancer Biology and Therapy, vol. 12, no. 10, pp. 908–914, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. J.-S. Oh, J.-J. Kim, J.-Y. Byun, and I.-A. Kim, “Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras,” International Journal of Radiation Oncology Biology Physics, vol. 76, no. 1, pp. 5–8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. S.-H. Jeong, H.-G. Wu, and W.-Y. Park, “LIN28B confers radio-resistance through the posttranscriptional control of KRAS,” Experimental and Molecular Medicine, vol. 41, no. 12, pp. 912–918, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Arora, R. Qureshi, S. Jin, A.-K. Park, and W.-Y. Park, “miR-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFκB1,” Experimental and Molecular Medicine, vol. 43, no. 5, pp. 298–304, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Salim, N. S. Akbar, D. Zong et al., “MiRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence,” British Journal of Cancer, vol. 107, no. 8, pp. 1361–1373, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Balça-Silva, S. S. Neves, A. C. Gonçalves et al., “Effect of miR-34b overexpression on the radiosensitivity of non-small cell lung cancer cell lines,” Anticancer Research, vol. 32, no. 5, pp. 1603–1609, 2012. View at Google Scholar · View at Scopus
  48. J. Mihatsch, M. Toulany, P. M. Bareiss et al., “Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro,” Radiotherapy & Oncology, vol. 99, no. 3, pp. 300–306, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. L. Lundholm, P. Hååg, D. Zong et al., “Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest,” Cell Death & Disease, vol. 4, article e478, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. P. Xia, W.-F. Gou, J.-J. Wang et al., “Distinct radiosensitivity of lung carcinoma stem-like side population and main population cells,” Cancer Biotherapy and Radiopharmaceuticals, vol. 28, no. 6, pp. 471–478, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. R. C. Friedman, K. K.-H. Farh, C. B. Burge, and D. P. Bartel, “Most mammalian mRNAs are conserved targets of microRNAs,” Genome Research, vol. 19, no. 1, pp. 92–105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. P. Sartipy, B. Olsson, J. Hyllner, and J. Synnergren, “Regulation of ‘stemness’ and stem cell differentiation by microRNAs,” IDrugs, vol. 12, no. 8, pp. 492–496, 2009. View at Google Scholar · View at Scopus
  53. S. Hua, X. Xiaotao, G. Renhua et al., “Reduced miR-31 and let-7 maintain the balance between differentiation and quiescence in lung cancer stem-like side population cells,” Biomedicine and Pharmacotherapy, vol. 66, no. 2, pp. 89–97, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Zhao, A. M. Bode, Y. Cao, and Z. Dong, “Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity,” Carcinogenesis, vol. 33, no. 11, pp. 2220–2227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Willers, C. G. Azzoli, W. L. Santivasi, and F. Xia, “Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer,” Cancer Journal, vol. 19, no. 3, pp. 200–207, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. L. Wu, J. G. Sun, R. Xu et al., “miR-18a enhancing radiosensitivity of A549 cells and its molecular mechanism,” The Journal of Third Military Medical University, vol. 35, no. 9, pp. 870–873, 2013 (Chinese). View at Google Scholar
  57. Y. Tang, J. Hou, G. Li et al., “ABCG2 regulates the pattern of self-renewing divisions in cisplatin-resistant non-small cell lung cancer cell lines,” Oncology Reports, vol. 32, no. 5, pp. 2168–2174, 2014. View at Google Scholar
  58. J. D. O'Flaherty, M. Barr, D. Fennell et al., “The cancer stem-cell hypothesis: Its emerging role in lung cancer biology and its relevance for future therapy,” Journal of Thoracic Oncology, vol. 7, no. 12, pp. 1880–1890, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. V. Tirino, R. Camerlingo, K. Bifulco et al., “TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction,” Cell Death and Disease, vol. 4, no. 5, article e620, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. Y.-L. Lou, F. Guo, F. Liu et al., “MiR-210 activates notch signaling pathway in angiogenesis induced by cerebral ischemia,” Molecular and Cellular Biochemistry, vol. 370, no. 1-2, pp. 45–51, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. V. G. Da Ros, I. Gutierrez-Perez, D. Ferres-Marco, and M. Dominguez, “Dampening the signals transduced through hedgehog via microRNA miR-7 facilitates notch-induced tumourigenesis,” PLoS Biology, vol. 11, no. 5, Article ID e1001554, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. D. M. Vallejo, E. Caparros, and M. Dominguez, “Targeting Notch signalling by the conserved miR-8/200 microRNA family in development and cancer cells,” The EMBO Journal, vol. 30, no. 4, pp. 756–769, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. G. Song, Y. Zhang, and L. Wang, “MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation,” Journal of Biological Chemistry, vol. 284, no. 46, pp. 31921–31927, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. H. Iida, M. Suzuki, R. Goitsuka, and H. Ueno, “Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2,” International Journal of Oncology, vol. 40, no. 1, pp. 71–79, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Diehn, R. W. Cho, N. A. Lobo et al., “Association of reactive oxygen species levels and radioresistance in cancer stem cells,” Nature, vol. 458, no. 7239, pp. 780–783, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. J. M. Brown, D. J. Carlson, and D. J. Brenner, “The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?” International Journal of Radiation Oncology Biology Physics, vol. 88, no. 2, pp. 254–262, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. B. Liu, H. Zhang, X. Duan et al., “Adenovirus-mediated wild-type p53 transfer radiosensitizes H1299 cells to subclinical-dose carbon-ion irradiation through the restoration of p53 function,” Cancer Biotherapy and Radiopharmaceuticals, vol. 24, no. 1, pp. 57–65, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. G. Bridge, R. Monteiro, S. Henderson et al., “The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis,” Blood, vol. 120, no. 25, pp. 5063–5072, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. V. Levina, A. Marrangoni, T. Wang et al., “Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop,” Cancer Research, vol. 70, no. 1, pp. 338–346, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. Z. Zheng, W. L. Ng, X. Zhang et al., “RNAi-mediated targeting of noncoding and coding sequences in DNA repair gene messages efficiently radiosensitizes human tumor cells,” Cancer Research, vol. 72, no. 5, pp. 1221–1228, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. Q. Yao, A.-M. Zhang, H. Ma et al., “Novel molecular beacons to monitor microRNAs in non-small-cell lung cancer,” Molecular and Cellular Probes, vol. 26, no. 5, pp. 182–187, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Baumann, M. Krause, and R. Hill, “Exploring the role of cancer stem cells in radioresistance,” Nature Reviews Cancer, vol. 8, no. 7, pp. 545–554, 2008. View at Publisher · View at Google Scholar · View at Scopus